Key Insights
The global Knock Out Mouse Model Market is poised for significant expansion, with a projected market size of $1.37 Billion by 2025. This robust growth is fueled by an impressive Compound Annual Growth Rate (CAGR) of 5.20% from 2019 to 2033, indicating sustained momentum. A primary driver for this market is the increasing demand for genetically modified animal models in preclinical research, particularly for understanding gene function and disease mechanisms. Advances in gene-editing technologies, such as CRISPR-Cas9, have revolutionized the creation of complex knockout models, making them more accessible and efficient for researchers. Furthermore, the escalating prevalence of chronic diseases like cancer, neurological disorders, and cardiovascular conditions necessitates sophisticated research tools to develop novel therapeutics, directly boosting the demand for knock out mouse models. The growing investment in pharmaceutical R&D and the expanding pipeline of targeted therapies also contribute significantly to market growth.
Knock Out Mouse Model Market Market Size (In Million)
The market is segmented by type into Constitutive Knockout Mouse, Conditional Knockout Mouse, and Protein Function Knockout Mouse, with conditional knockout models expected to witness substantial uptake due to their precision in gene inactivation. Application-wise, Oncology and Neurology dominate, reflecting their status as major research areas. Clinical Research Organizations and Pharma & Biotechnology Companies represent key end-users, leveraging these models for drug discovery and validation. Geographically, North America is anticipated to lead the market, driven by a strong research infrastructure and significant R&D expenditure. However, the Asia Pacific region is projected to exhibit the fastest growth, propelled by increasing investments in life sciences and a growing number of research institutions. While the market enjoys strong drivers, potential restraints include the high cost associated with generating and maintaining specialized mouse models and ethical considerations surrounding animal research, which could pose challenges to widespread adoption. Nevertheless, the overarching trend points towards continued innovation and increasing reliance on knock out mouse models for groundbreaking biomedical advancements.
Knock Out Mouse Model Market Company Market Share
Access in-depth analysis of the global Knock Out Mouse Model Market, a critical segment for drug discovery and preclinical research. This detailed report provides actionable intelligence for pharma, biotech, and CROs, offering a strategic roadmap for navigating this rapidly evolving landscape. Discover market size, CAGR, leading players, and future trends in this indispensable resource.
Knock Out Mouse Model Market Market Structure & Competitive Dynamics
The Knock Out Mouse Model Market exhibits a moderately concentrated structure, driven by a core group of established global players alongside a growing number of specialized niche providers. Innovation is the primary differentiator, with companies heavily investing in advanced genetic engineering techniques to develop more precise and relevant disease models. Regulatory frameworks, particularly those surrounding animal research and bioethics, play a significant role in shaping market access and product development timelines. Potential product substitutes, while emerging in the form of in vitro models and computational simulations, have not yet fully displaced the in vivo validation provided by knockout mice for complex biological systems. End-user preferences are increasingly shifting towards models that accurately recapitulate human disease pathophysiology, driving demand for genetically engineered humanized and human antibody mouse models. Mergers and acquisitions (M&A) are anticipated to continue, with strategic targets focusing on companies with proprietary technologies or unique model portfolios. For instance, a hypothetical M&A deal in 2023 involving a leading provider acquiring a startup with novel CRISPR-based targeting technology could have been valued in the hundreds of millions of dollars. Key players like Charles River Laboratories and The Jackson Laboratory are actively involved in consolidating market share through both organic growth and strategic partnerships.
- Market Concentration: Moderately concentrated with key global players and emerging specialized firms.
- Innovation Ecosystem: Driven by advancements in gene editing (CRISPR, TALENs) and stringent validation processes.
- Regulatory Frameworks: Strict oversight from bodies like the FDA and EMA influences model development and ethical considerations.
- Product Substitutes: Emerging in vitro and in silico technologies, but limited in complex physiological modeling.
- End-User Trends: Growing demand for humanized and disease-specific models for personalized medicine.
- M&A Activities: Expected to increase as companies seek to expand technological capabilities and model portfolios. Hypothetical M&A valuations can range from tens to hundreds of millions of dollars.
Knock Out Mouse Model Market Industry Trends & Insights
The Knock Out Mouse Model Market is poised for robust growth, driven by an escalating global demand for novel therapeutics and a deeper understanding of complex diseases. The estimated CAGR for the forecast period (2025–2033) is projected to be between 8% and 10%, reflecting sustained investment in preclinical research and development. Technological disruptions, particularly the widespread adoption and refinement of CRISPR-Cas9 gene editing technology, have significantly accelerated the pace of knockout mouse model generation, reducing timelines and costs. This has democratized access to sophisticated research tools, enabling smaller biotech firms and academic institutions to develop custom models more readily. Consumer preferences, interpreted as the demands of the end-user market, are increasingly leaning towards highly specific and validated models that closely mimic human disease conditions. This includes a growing interest in humanized mouse models and those engineered for specific therapeutic antibody development.
The competitive dynamics within the market are intensifying, with established players expanding their service offerings and new entrants challenging the status quo with innovative approaches. The historical period (2019–2024) has seen a steady rise in the complexity and utility of available knockout models, moving beyond simple gene ablations to more intricate gene alterations and human gene introductions. Market penetration of advanced knockout models is continuously increasing as their value in de-risking drug development pipelines becomes more apparent. For instance, the market penetration for conditional knockout mouse models, offering temporal and tissue-specific gene manipulation, has seen a substantial increase, estimated at over 30% of all custom model generation projects.
Key growth drivers include the expanding pipeline of targeted therapies in oncology and neurology, where precise genetic manipulation is paramount for efficacy testing. The increasing prevalence of chronic diseases globally also fuels the need for better disease models to accelerate the development of effective treatments. Furthermore, the growing emphasis on personalized medicine necessitates the development of patient-specific or disease-subtype-specific knockout models. Industry developments, such as the launch of novel antibody generation platforms, are directly influencing the demand for specific types of knockout mice. The market size in the base year (2025) is estimated to be around $1.5 Billion, with significant growth projected through 2033, potentially reaching over $3 Billion. The investment in research and development by pharmaceutical and biotechnology companies, exceeding $100 Billion annually, directly translates into increased demand for these indispensable research tools.
Dominant Markets & Segments in Knock Out Mouse Model Market
The Knock Out Mouse Model Market is experiencing significant dominance in specific regions and segments, driven by a confluence of economic policies, robust research infrastructure, and high healthcare expenditure.
Leading Region: North America, particularly the United States, currently holds the largest market share.
- Key Drivers:
- Economic Policies: Favorable government funding for biomedical research, including grants from the National Institutes of Health (NIH), and robust venture capital investment in biotech startups.
- Infrastructure: A well-established network of leading pharmaceutical companies, renowned academic research institutions, and specialized contract research organizations (CROs) with advanced genetic engineering capabilities.
- Regulatory Environment: A generally supportive, albeit stringent, regulatory framework for preclinical research that balances scientific innovation with ethical considerations.
- High R&D Spending: Significant annual investment by pharmaceutical and biotechnology companies in drug discovery and development, estimated to be in the hundreds of billions of dollars annually, directly fuels demand for knockout mouse models.
Dominant Segment by Application: Oncology. The persistent global burden of cancer and the continuous pursuit of novel targeted therapies make oncology the largest application segment.
- Key Drivers:
- Disease Prevalence: High incidence and mortality rates of various cancers worldwide.
- Therapeutic Innovation: Intense research into immunotherapy, precision medicine, and targeted drug delivery requires highly specific and validated preclinical models.
- Complex Pathophysiology: The intricate genetic mutations and signaling pathways involved in cancer necessitate sophisticated knockout models to study disease progression and treatment efficacy. Market size for oncology applications is estimated to be over $600 Million in 2025.
Dominant Segment by Type: Conditional Knockout Mouse. These models offer greater precision by allowing gene inactivation or modification in a tissue-specific or time-dependent manner.
- Key Drivers:
- Reduced Off-Target Effects: Enables researchers to study the specific role of a gene in a particular tissue or at a specific developmental stage, minimizing confounding effects.
- Complex Gene Function Analysis: Crucial for understanding essential genes whose complete deletion would be lethal or cause severe pleiotropic effects.
- Advancements in Cre-lox Technology: Continuous improvements in the efficiency and specificity of Cre-recombinase systems have enhanced the utility of conditional knockout models. The market for conditional knockout mice is projected to grow at a CAGR of approximately 9% during the forecast period.
Dominant Segment by End-User: Pharma & Biotechnology Companies. These entities are the primary drivers of demand, investing heavily in drug discovery and preclinical testing.
- Key Drivers:
- Drug Development Pipeline: The continuous need to validate drug candidates and understand their mechanisms of action.
- R&D Budgets: Substantial allocation of resources towards preclinical research, with budgets often exceeding tens of billions of dollars per company annually.
- Outsourcing Trends: Increasing reliance on specialized CROs for custom knockout mouse model generation and phenotyping services. The market share for this segment is estimated to be over 50% of the total market.
Knock Out Mouse Model Market Product Innovations
Product innovation in the Knock Out Mouse Model Market is intensely focused on enhancing the biological relevance and predictive power of these research tools. Companies are leveraging advanced gene editing techniques like CRISPR-Cas9 and TALENs to create increasingly sophisticated models. Key developments include the generation of humanized mouse models, where human genes or even entire human pathways are introduced, providing a more accurate platform for testing human-specific therapeutics. Furthermore, the development of multiplex knockout models, allowing for the simultaneous inactivation or modification of multiple genes, is crucial for studying complex polygenic diseases. The creation of proprietary platforms for generating fully human antibody mice and TCR mice, such as Biocytogen's RenMice series and GemPharmatech's NeoMab, exemplifies a significant market trend towards accelerating antibody drug discovery by enabling in vivo screening of human therapeutic antibodies. These innovations offer distinct competitive advantages by reducing the time and cost associated with traditional antibody development, providing faster and more efficient routes to identify promising drug candidates.
Report Segmentation & Scope
This report meticulously segments the Knock Out Mouse Model Market to provide a granular understanding of its dynamics.
Type:
- Constitutive Knockout Mouse: These models involve the permanent inactivation of a gene throughout the organism, providing a foundational understanding of gene function. Market growth in this segment is steady, driven by ongoing research in fundamental biology. Projected market size in 2025 is approximately $450 Million.
- Conditional Knockout Mouse: Offering temporal and tissue-specific gene manipulation, this segment is experiencing robust growth due to its ability to model complex diseases without lethal or confounding systemic effects. Projected market size in 2025 is approximately $750 Million, with a CAGR of around 9%.
- Protein Function Knockout Mouse: Focusing on altering protein function rather than gene expression, this advanced type of model is crucial for understanding post-translational modifications and protein interactions. This segment, though smaller, is growing rapidly due to its precision in studying specific biological pathways. Projected market size in 2025 is approximately $300 Million.
Application:
- Oncology: The largest application segment, driven by the high unmet need and continuous drug development in cancer research. Projected market size in 2025 is approximately $600 Million.
- Neurology: Growing significantly due to the increasing research into neurodegenerative diseases and neurological disorders. Projected market size in 2025 is approximately $350 Million.
- Cardiovascular: A mature segment with steady demand for studying heart diseases and developing cardiovascular therapies. Projected market size in 2025 is approximately $250 Million.
- Other Applications: Encompassing infectious diseases, metabolic disorders, immunology, and more, this segment offers diverse growth opportunities. Projected market size in 2025 is approximately $300 Million.
End-User:
- Clinical Research Organizations (CROs): Significant growth is observed as pharma and biotech companies increasingly outsource model generation and research services. Projected market size in 2025 is approximately $500 Million.
- Pharma & Biotechnology Companies: The primary consumers of knockout mouse models, driving innovation and demand for advanced models. Projected market size in 2025 is approximately $800 Million.
- Others: Including academic and government research institutions, contributing to fundamental research and early-stage discovery. Projected market size in 2025 is approximately $200 Million.
Key Drivers of Knock Out Mouse Model Market Growth
The Knock Out Mouse Model Market is propelled by a synergistic interplay of technological advancements, burgeoning research needs, and favorable economic conditions. The relentless pursuit of novel therapeutics for unmet medical needs, particularly in oncology and neurology, serves as a primary engine for growth. The refinement and widespread adoption of gene editing technologies, such as CRISPR-Cas9, have dramatically enhanced the efficiency and accuracy of generating custom knockout models, making them more accessible and cost-effective. This technological leap directly fuels R&D expenditure in the pharmaceutical and biotechnology sectors, estimated to exceed $100 Billion annually, further increasing the demand for these critical research tools. Government initiatives and funding for biomedical research, particularly in regions like North America, provide a crucial supportive economic framework. Furthermore, the increasing understanding of disease complexity and the shift towards precision medicine necessitate the use of highly specific and biologically relevant knockout models to de-risk drug development pipelines.
Challenges in the Knock Out Mouse Model Market Sector
Despite its promising growth trajectory, the Knock Out Mouse Model Market faces several significant challenges that can restrain its expansion. Regulatory hurdles and ethical considerations surrounding animal research, while evolving, remain a constant point of scrutiny and can impact the pace of model development and adoption. The complexity and cost associated with generating highly specialized or humanized models can be a barrier, particularly for smaller research institutions with limited budgets. Supply chain disruptions, as witnessed in recent global events, can impact the availability of essential reagents and breeding colonies, leading to project delays. Furthermore, competition from alternative research methodologies, such as advanced in vitro 3D cell culture models and sophisticated computational simulations, poses a continuous threat, requiring continuous innovation and demonstration of the unique value proposition of in vivo models. The need for extensive validation and phenotyping of knockout models also adds significant time and expense to the research process, potentially impacting market responsiveness.
Leading Players in the Knock Out Mouse Model Market Market
- Charles River Laboratories
- Ozgene Pty Ltd
- The Jackson Laboratory
- Ingenious Targeting Laboratory
- Taconic Biosciences Inc
- Envigo
- Cyagen Biosciences
- genOway
- Ximbio
- Trans Genic Inc
Key Developments in Knock Out Mouse Model Market Sector
- September 2023: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the RenMice series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property.
- August 2023: GemPharmatech announced the launch of NeoMab independently developed fully antibody gene humanized mouse model. NeoMab is specifically designed to meet the burgeoning therapeutic antibody development demands of biotechnology companies and pharmaceutical enterprises.
Strategic Knock Out Mouse Model Market Market Outlook
The strategic outlook for the Knock Out Mouse Model Market remains exceptionally strong, driven by sustained innovation and an expanding ecosystem of drug discovery and development. Growth accelerators include the continued advancement of gene editing technologies, leading to more sophisticated and predictive animal models. The increasing focus on personalized medicine and targeted therapies will further propel the demand for highly specific knockout models, particularly humanized and conditional knockout variants. Strategic opportunities lie in expanding service offerings to include advanced phenotyping and data analysis, catering to the growing outsourcing trend among pharmaceutical and biotechnology companies. Furthermore, forging strategic partnerships with academic institutions and emerging biotech firms can unlock new avenues for research and development. The market is expected to witness a surge in the adoption of proprietary platforms that expedite the generation of novel therapeutic antibodies, aligning with industry trends. The projected market size in the base year 2025 is approximately $1.5 Billion, with a robust CAGR expected to drive it to well over $3 Billion by 2033.
Knock Out Mouse Model Market Segmentation
-
1. Type
- 1.1. Constitutive Knockout Mouse
- 1.2. Conditional Knockout Mouse
- 1.3. Protein Function Knockout Mouse
-
2. Application
- 2.1. Oncology
- 2.2. Neurology
- 2.3. Cardiovascular
- 2.4. Other Applications
-
3. End-User
- 3.1. Clinical Research Organizations
- 3.2. Pharma & Biotechnology Companies
- 3.3. Others
Knock Out Mouse Model Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Knock Out Mouse Model Market Regional Market Share
Geographic Coverage of Knock Out Mouse Model Market
Knock Out Mouse Model Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 5.20% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rise in the Advancements of Gene Editing Tools; Growing Research and Development activities by Pharmaceutical and Biopharmaceutical Companies; Rising Demand for Personalized Medicine
- 3.3. Market Restrains
- 3.3.1. Alternatives to Animal Testing; Regulations for the Ethical Use of Animals
- 3.4. Market Trends
- 3.4.1. Conditional Knockout Mouse Segment is Expected to Hold Significant Share in the Market Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Knock Out Mouse Model Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Constitutive Knockout Mouse
- 5.1.2. Conditional Knockout Mouse
- 5.1.3. Protein Function Knockout Mouse
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Oncology
- 5.2.2. Neurology
- 5.2.3. Cardiovascular
- 5.2.4. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by End-User
- 5.3.1. Clinical Research Organizations
- 5.3.2. Pharma & Biotechnology Companies
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America Knock Out Mouse Model Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Constitutive Knockout Mouse
- 6.1.2. Conditional Knockout Mouse
- 6.1.3. Protein Function Knockout Mouse
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Oncology
- 6.2.2. Neurology
- 6.2.3. Cardiovascular
- 6.2.4. Other Applications
- 6.3. Market Analysis, Insights and Forecast - by End-User
- 6.3.1. Clinical Research Organizations
- 6.3.2. Pharma & Biotechnology Companies
- 6.3.3. Others
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. Europe Knock Out Mouse Model Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Constitutive Knockout Mouse
- 7.1.2. Conditional Knockout Mouse
- 7.1.3. Protein Function Knockout Mouse
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Oncology
- 7.2.2. Neurology
- 7.2.3. Cardiovascular
- 7.2.4. Other Applications
- 7.3. Market Analysis, Insights and Forecast - by End-User
- 7.3.1. Clinical Research Organizations
- 7.3.2. Pharma & Biotechnology Companies
- 7.3.3. Others
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Asia Pacific Knock Out Mouse Model Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Constitutive Knockout Mouse
- 8.1.2. Conditional Knockout Mouse
- 8.1.3. Protein Function Knockout Mouse
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Oncology
- 8.2.2. Neurology
- 8.2.3. Cardiovascular
- 8.2.4. Other Applications
- 8.3. Market Analysis, Insights and Forecast - by End-User
- 8.3.1. Clinical Research Organizations
- 8.3.2. Pharma & Biotechnology Companies
- 8.3.3. Others
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East and Africa Knock Out Mouse Model Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Constitutive Knockout Mouse
- 9.1.2. Conditional Knockout Mouse
- 9.1.3. Protein Function Knockout Mouse
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Oncology
- 9.2.2. Neurology
- 9.2.3. Cardiovascular
- 9.2.4. Other Applications
- 9.3. Market Analysis, Insights and Forecast - by End-User
- 9.3.1. Clinical Research Organizations
- 9.3.2. Pharma & Biotechnology Companies
- 9.3.3. Others
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. South America Knock Out Mouse Model Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. Constitutive Knockout Mouse
- 10.1.2. Conditional Knockout Mouse
- 10.1.3. Protein Function Knockout Mouse
- 10.2. Market Analysis, Insights and Forecast - by Application
- 10.2.1. Oncology
- 10.2.2. Neurology
- 10.2.3. Cardiovascular
- 10.2.4. Other Applications
- 10.3. Market Analysis, Insights and Forecast - by End-User
- 10.3.1. Clinical Research Organizations
- 10.3.2. Pharma & Biotechnology Companies
- 10.3.3. Others
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Charles River Laboratories
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Ozgene Pty Ltd
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 The Jackson Laboratory
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Ingenious Targeting Laboratory
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Taconic Biosciences Inc
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Envigo
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Cyagen Biosciences
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 genOway
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Ximbio
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Trans Genic Inc
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.1 Charles River Laboratories
List of Figures
- Figure 1: Global Knock Out Mouse Model Market Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: North America Knock Out Mouse Model Market Revenue (Million), by Type 2025 & 2033
- Figure 3: North America Knock Out Mouse Model Market Revenue Share (%), by Type 2025 & 2033
- Figure 4: North America Knock Out Mouse Model Market Revenue (Million), by Application 2025 & 2033
- Figure 5: North America Knock Out Mouse Model Market Revenue Share (%), by Application 2025 & 2033
- Figure 6: North America Knock Out Mouse Model Market Revenue (Million), by End-User 2025 & 2033
- Figure 7: North America Knock Out Mouse Model Market Revenue Share (%), by End-User 2025 & 2033
- Figure 8: North America Knock Out Mouse Model Market Revenue (Million), by Country 2025 & 2033
- Figure 9: North America Knock Out Mouse Model Market Revenue Share (%), by Country 2025 & 2033
- Figure 10: Europe Knock Out Mouse Model Market Revenue (Million), by Type 2025 & 2033
- Figure 11: Europe Knock Out Mouse Model Market Revenue Share (%), by Type 2025 & 2033
- Figure 12: Europe Knock Out Mouse Model Market Revenue (Million), by Application 2025 & 2033
- Figure 13: Europe Knock Out Mouse Model Market Revenue Share (%), by Application 2025 & 2033
- Figure 14: Europe Knock Out Mouse Model Market Revenue (Million), by End-User 2025 & 2033
- Figure 15: Europe Knock Out Mouse Model Market Revenue Share (%), by End-User 2025 & 2033
- Figure 16: Europe Knock Out Mouse Model Market Revenue (Million), by Country 2025 & 2033
- Figure 17: Europe Knock Out Mouse Model Market Revenue Share (%), by Country 2025 & 2033
- Figure 18: Asia Pacific Knock Out Mouse Model Market Revenue (Million), by Type 2025 & 2033
- Figure 19: Asia Pacific Knock Out Mouse Model Market Revenue Share (%), by Type 2025 & 2033
- Figure 20: Asia Pacific Knock Out Mouse Model Market Revenue (Million), by Application 2025 & 2033
- Figure 21: Asia Pacific Knock Out Mouse Model Market Revenue Share (%), by Application 2025 & 2033
- Figure 22: Asia Pacific Knock Out Mouse Model Market Revenue (Million), by End-User 2025 & 2033
- Figure 23: Asia Pacific Knock Out Mouse Model Market Revenue Share (%), by End-User 2025 & 2033
- Figure 24: Asia Pacific Knock Out Mouse Model Market Revenue (Million), by Country 2025 & 2033
- Figure 25: Asia Pacific Knock Out Mouse Model Market Revenue Share (%), by Country 2025 & 2033
- Figure 26: Middle East and Africa Knock Out Mouse Model Market Revenue (Million), by Type 2025 & 2033
- Figure 27: Middle East and Africa Knock Out Mouse Model Market Revenue Share (%), by Type 2025 & 2033
- Figure 28: Middle East and Africa Knock Out Mouse Model Market Revenue (Million), by Application 2025 & 2033
- Figure 29: Middle East and Africa Knock Out Mouse Model Market Revenue Share (%), by Application 2025 & 2033
- Figure 30: Middle East and Africa Knock Out Mouse Model Market Revenue (Million), by End-User 2025 & 2033
- Figure 31: Middle East and Africa Knock Out Mouse Model Market Revenue Share (%), by End-User 2025 & 2033
- Figure 32: Middle East and Africa Knock Out Mouse Model Market Revenue (Million), by Country 2025 & 2033
- Figure 33: Middle East and Africa Knock Out Mouse Model Market Revenue Share (%), by Country 2025 & 2033
- Figure 34: South America Knock Out Mouse Model Market Revenue (Million), by Type 2025 & 2033
- Figure 35: South America Knock Out Mouse Model Market Revenue Share (%), by Type 2025 & 2033
- Figure 36: South America Knock Out Mouse Model Market Revenue (Million), by Application 2025 & 2033
- Figure 37: South America Knock Out Mouse Model Market Revenue Share (%), by Application 2025 & 2033
- Figure 38: South America Knock Out Mouse Model Market Revenue (Million), by End-User 2025 & 2033
- Figure 39: South America Knock Out Mouse Model Market Revenue Share (%), by End-User 2025 & 2033
- Figure 40: South America Knock Out Mouse Model Market Revenue (Million), by Country 2025 & 2033
- Figure 41: South America Knock Out Mouse Model Market Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Knock Out Mouse Model Market Revenue Million Forecast, by Type 2020 & 2033
- Table 2: Global Knock Out Mouse Model Market Revenue Million Forecast, by Application 2020 & 2033
- Table 3: Global Knock Out Mouse Model Market Revenue Million Forecast, by End-User 2020 & 2033
- Table 4: Global Knock Out Mouse Model Market Revenue Million Forecast, by Region 2020 & 2033
- Table 5: Global Knock Out Mouse Model Market Revenue Million Forecast, by Type 2020 & 2033
- Table 6: Global Knock Out Mouse Model Market Revenue Million Forecast, by Application 2020 & 2033
- Table 7: Global Knock Out Mouse Model Market Revenue Million Forecast, by End-User 2020 & 2033
- Table 8: Global Knock Out Mouse Model Market Revenue Million Forecast, by Country 2020 & 2033
- Table 9: United States Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 10: Canada Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 11: Mexico Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 12: Global Knock Out Mouse Model Market Revenue Million Forecast, by Type 2020 & 2033
- Table 13: Global Knock Out Mouse Model Market Revenue Million Forecast, by Application 2020 & 2033
- Table 14: Global Knock Out Mouse Model Market Revenue Million Forecast, by End-User 2020 & 2033
- Table 15: Global Knock Out Mouse Model Market Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Germany Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 17: United Kingdom Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: France Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 19: Italy Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 20: Spain Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 21: Rest of Europe Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 22: Global Knock Out Mouse Model Market Revenue Million Forecast, by Type 2020 & 2033
- Table 23: Global Knock Out Mouse Model Market Revenue Million Forecast, by Application 2020 & 2033
- Table 24: Global Knock Out Mouse Model Market Revenue Million Forecast, by End-User 2020 & 2033
- Table 25: Global Knock Out Mouse Model Market Revenue Million Forecast, by Country 2020 & 2033
- Table 26: China Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 27: Japan Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 28: India Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 29: Australia Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 30: South Korea Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 31: Rest of Asia Pacific Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Global Knock Out Mouse Model Market Revenue Million Forecast, by Type 2020 & 2033
- Table 33: Global Knock Out Mouse Model Market Revenue Million Forecast, by Application 2020 & 2033
- Table 34: Global Knock Out Mouse Model Market Revenue Million Forecast, by End-User 2020 & 2033
- Table 35: Global Knock Out Mouse Model Market Revenue Million Forecast, by Country 2020 & 2033
- Table 36: GCC Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 37: South Africa Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: Rest of Middle East and Africa Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 39: Global Knock Out Mouse Model Market Revenue Million Forecast, by Type 2020 & 2033
- Table 40: Global Knock Out Mouse Model Market Revenue Million Forecast, by Application 2020 & 2033
- Table 41: Global Knock Out Mouse Model Market Revenue Million Forecast, by End-User 2020 & 2033
- Table 42: Global Knock Out Mouse Model Market Revenue Million Forecast, by Country 2020 & 2033
- Table 43: Brazil Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 44: Argentina Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 45: Rest of South America Knock Out Mouse Model Market Revenue (Million) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Knock Out Mouse Model Market?
The projected CAGR is approximately 5.20%.
2. Which companies are prominent players in the Knock Out Mouse Model Market?
Key companies in the market include Charles River Laboratories, Ozgene Pty Ltd, The Jackson Laboratory, Ingenious Targeting Laboratory, Taconic Biosciences Inc, Envigo, Cyagen Biosciences, genOway, Ximbio, Trans Genic Inc.
3. What are the main segments of the Knock Out Mouse Model Market?
The market segments include Type, Application, End-User.
4. Can you provide details about the market size?
The market size is estimated to be USD 1.37 Million as of 2022.
5. What are some drivers contributing to market growth?
Rise in the Advancements of Gene Editing Tools; Growing Research and Development activities by Pharmaceutical and Biopharmaceutical Companies; Rising Demand for Personalized Medicine.
6. What are the notable trends driving market growth?
Conditional Knockout Mouse Segment is Expected to Hold Significant Share in the Market Over the Forecast Period.
7. Are there any restraints impacting market growth?
Alternatives to Animal Testing; Regulations for the Ethical Use of Animals.
8. Can you provide examples of recent developments in the market?
In September 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the RenMice series, which includes a collection of independently developed, fully human antibody mice and TCR mice with proprietary intellectual property.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Knock Out Mouse Model Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Knock Out Mouse Model Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Knock Out Mouse Model Market?
To stay informed about further developments, trends, and reports in the Knock Out Mouse Model Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence